Doctor profile · Federal record

Dr. Scott Lewis, D.O.

Rheumatology Physician (CMS: Rheumatology) · Somerset, KY

  • NPI 1336368505
  • Accepts Medicare
  • 22 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
26 Oxford Way, Suite D
Somerset, KY 425032813
(606) 802-2300
fax (606) 802-2400
Mailing address
26 Oxford Way Ste A
Somerset, KY 425032813

Credentials & registration

NPPES · NUCC
NPI registered
April 2007 — 19 yrs on file
Profile last updated
January 28, 2026
Year of graduation
2004 — 22 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State license (1)
Kentucky #03390

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1336368505. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
140,536
Distinct HCPCS
10
Medicare allowed
$1,887,946
HCPCS Description Services Patients Avg allowed
J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 60,800 61 $5
J3262 Injection, tocilizumab, 1 mg 33,992 28 $6
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 19,500 119 $42
J1602 Injection, golimumab, 1 mg, for intravenous use 13,098 39 $13
J3111 Injection, romosozumab-aqqg, 1 mg 3,570 12 $10
J0897 Injection, denosumab, 1 mg 2,280 35 $23
J0490 Injection, belimumab, 10 mg 1,636 11 $46
86235 Measurement of antibody for assessment of autoimmune disorder, any method 1,243 137 $17
J1745 Injection, infliximab, excludes biosimilar, 10 mg 1,116 16 $33
99214 Established patient office or other outpatient visit, 30-39 minutes 490 304 $117

In context: peer comparison

Among 2 peers in Somerset Rheumatology Physician, average services per provider: 4,443. This provider delivers 32× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$3,085
Transactions
185
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Abbvie INC. 43 $703.46
Novartis Pharmaceuticals Corporation 20 $407.65
Janssen Biotech, INC. 14 $337.16
Amgen INC. 25 $295.40
E.R. Squibb & Sons, L.L.C. 19 $264.71
Ucb, INC. 15 $243.29
AstraZeneca Pharmaceuticals Lp 9 $175.03
Aurinia Pharma U.S., INC. 17 $166.00
GlaxoSmithKline, LLC. 8 $138.73
Mallinckrodt Hospital Products INC. 3 $94.34
Pfizer INC. 5 $85.20
Radius Health, INC. 3 $47.42
Ani Pharmaceuticals, INC. 2 $34.84
Genzyme Corporation 1 $31.92
Alexion Pharmaceuticals, INC. 1 $25.20

By nature of payment

Food and Beverage
$2,940
Education
$145

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
2,588
Patients
914
Total drug cost
$4,334,078
Drug Type Claims Patients Total cost
Hydroxychloroquine Sulfate Generic 771 314 $53,055
Prednisone Generic 455 202 $4,291
Methotrexate (Methotrexate Sodium) Brand 339 137 $10,621
Humira(Cf) Pen (Adalimumab) Brand 167 27 $1,485,672
Duloxetine Hcl Generic 146 62 $2,893
Leflunomide Generic 115 40 $9,111
Orencia Clickject (Abatacept) Brand 102 15 $610,300
Xeljanz Xr (Tofacitinib Citrate) Brand 91 15 $559,842
Rinvoq (Upadacitinib) Brand 79 15 $533,343
Tramadol Hcl Generic 70 21 $566

Frequently asked questions

Auto-generated from federal data
What is Dr. Scott Lewis's medical specialty?
Dr. Scott Lewis practices Rheumatology Physician in Somerset, KY.
Where does Dr. Scott Lewis practice?
Dr. Scott Lewis practices at 26 Oxford Way, Somerset, KY 425032813. Office phone: 6068022300.
What is Dr. Scott Lewis's NPI?
Dr. Scott Lewis's National Provider Identifier (NPI) is 1336368505, issued by NPPES.
Does Dr. Scott Lewis accept Medicare assignment?
Yes. Dr. Scott Lewis accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Scott Lewis commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129). Source: CMS Medicare Physician & Other Practitioners file.